Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib Combined With GEMOX in Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT04500561Phase 2Unknown
- Sponsor
- Yingli Pharma
- Start
- Aug 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of linperlisib in diffuse large B-cell lymphoma (DLBCL), sponsored by Yingli Pharma. Status: unknown.
02
Drugs
linperlisib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT04500561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500561.